James Rothman's Net Worth
$12 Million
Who is James Rothman?
James Rothman has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include Adhera Therapeutics, Inc., ACA Capital Holdings Inc, Bruker Cellular Analysis, Inc., and INTROGEN THERAPEUTICS INC.
SEC CIK
James Rothman's CIK is 0001380378
Past Insider Trading and Trends
2008 was James Rothman's most active year for acquiring shares with 6 total transactions. James Rothman's most active month to acquire stocks was the month of July. 2021 was James Rothman's most active year for disposing of shares, totalling 8 transactions. James Rothman's most active month to dispose stocks was the month of February. 2020 saw James Rothman paying a total of $947,500.00 for 375,000 shares, this is the most they've acquired in one year. In 2021 James Rothman cashed out on 236,155 shares for a total of $13,020,371.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adhera Therapeutics, Inc. (ATRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACA Capital Holdings Inc No price found
Sr. Mng. Dir., Strct. CreditJames Rothman owns 55,080.91 units of Common Stock.acquired a total of 55,080.91 shares in ACA Capital Holdings Inc at a cost of $6,314.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.85% | 1K |
$6.31 | $6,314.00 | 55.08K |
Aug 1
| |||
Form 4
|
∞
| 54.08K |
—
|
—
| 54.08K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bruker Cellular Analysis, Inc. No price found
InvestorJames Rothman used to own units in Common Stock but no longer holds any shares there. From 2020 to 2023 James Rothman acquired a total of 399,965 shares in Bruker Cellular Analysis, Inc. at a cost of $1,044,900.00, James also disposed a total of 354,965 shares of Bruker Cellular Analysis, Inc. equalling to $13,020,371.72.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -118.81K |
—
|
—
|
0
|
Oct 2
| |||
Form 4
| +13.56% | 19.57K |
—
|
—
| 163.81K |
May 26
| |||
Form 4
| +2.85% | 4K |
$24.35 | $97,400.00 | 144.25K |
Nov 8
| |||
Form 4
| +1.01% | 1.4K |
—
|
—
| 140.25K |
May 14
| |||
Form 4
| -50.21% | -140.00K |
$52.75 | -$7,385,000.00 | 138.84K |
Mar 5
| |||
Form 4
|
∞
| 278.85K |
$30.57 | -$4,687,871.72 | 278.85K |
Aug 3 - Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTROGEN THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||